<DOC>
	<DOC>NCT02692586</DOC>
	<brief_summary>Evaluate the safety and effectiveness of the FlowTriever System for use in the removal of emboli from the pulmonary arteries in the treatment of acute pulmonary embolism.</brief_summary>
	<brief_title>FlowTriever Pulmonary Embolectomy Clinical Study</brief_title>
	<detailed_description />
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<criteria>Clinical signs, symptoms and presentation consistent with acute PE PE symptom duration ≤ 14 days CTA evidence of proximal PE RV/LV ratio ≥ 0.9 without syncope Systolic BP ≥ 90 mmHg Stable heart rate &lt;130 BPM prior to procedure Patient deemed medically eligible for interventional procedure(s), per institutional guidelines and/or clinical judgment Thrombolytic use within 30 days of baseline CTA Pulmonary hypertension with peak PAP &gt; 70 mmHg by right heart catheterizatoin Vasopressor requirement after fluids to keep pressure ≥ 90 mmHg FiO2 requirement &gt; 40% or &gt; 6 LPM to keep oxygen saturation &gt; 90% Hematocrit &lt; 28% within 6 hours of index procedure Platelets &lt; 100,000/µL Serum creatinine &gt; 1.8 mg/dL INR &gt; 3 Major trauma ISS &gt; 15 Presence of intracardiac lead in right ventricle or atrium placed within 6 months Cardiovascular or pulmonary surgery within last 7 days Actively progressing cancer Known bleeding diathesis or coagulation disorder Left bundle branch block History of severe or chronic pulmonary arterial hypertension History of chronic left heart disease with left ventricular ejection fraction ≤ 30% History of uncompensated heart failure History of underlying lung disease that is oxygen dependent History of chest irradiation History of HIT Any contraindication to systemic or therapeutic doses of heparin or anticoagulants Known anaphylactic reaction to radiographic contrast agents that cannot be pretreated Imaging evidence or other evidence that suggests the subject is not appropriate for mechanical thrombectomy intervention Life expectancy of &lt; 90 days Female who is pregnant or nursing Current participation in another investigational drug or device treatment study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Thromboembolism</keyword>
	<keyword>Thrombectomy</keyword>
	<keyword>Right Heart Strain</keyword>
	<keyword>Submassive PE</keyword>
	<keyword>Right Ventricle Dysfunction</keyword>
	<keyword>Massive PE</keyword>
</DOC>